These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current challenges with supply-chain integrity and the threat to the quality of marketed drugs. Paxton M Clin Pharmacol Ther; 2011 Feb; 89(2):316-9. PubMed ID: 21178987 [No Abstract] [Full Text] [Related]
4. Strategy for surveillance of adverse drug events. Bright RA Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403 [No Abstract] [Full Text] [Related]
5. Regulators scramble to tighten loopholes after heparin debacle. Jia H Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756 [No Abstract] [Full Text] [Related]
6. FDA attempting to overcome major roadblocks in monitoring drug safety. Zielinski SL J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645 [No Abstract] [Full Text] [Related]
7. Pharmaceutical postmarket review: fact or fiction? Schanz SJ Food Drug Law J; 2007; 62(3):493-500. PubMed ID: 17915391 [No Abstract] [Full Text] [Related]
8. Bad medicine. Sheridan C Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284 [No Abstract] [Full Text] [Related]
9. Process analytical technology and ASTM Committee E55. Watts DC; Afnan AM; Hussain AS Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856 [No Abstract] [Full Text] [Related]
10. The unfinished business of U.S. drug safety regulation. Evans BJ; Flockhart DA Food Drug Law J; 2006; 61(1):45-63. PubMed ID: 16838457 [No Abstract] [Full Text] [Related]
11. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration? Zelenay JL Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773 [No Abstract] [Full Text] [Related]
12. Pharmaceutical GMPs. Bobrowicz G Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629 [No Abstract] [Full Text] [Related]
13. Sporicidin update: are the government's regulatory teeth tearing a hole in industry? Healthc Hazard Mater Manage; 1993 Apr; 6(7):10-1. PubMed ID: 10125098 [No Abstract] [Full Text] [Related]
14. "Safer, but not safe enough". Crombie HD Conn Med; 2006; 70(10):645. PubMed ID: 17190395 [No Abstract] [Full Text] [Related]
15. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering? Purnhagen KP Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663 [No Abstract] [Full Text] [Related]
16. Mandatory post marketing studies. Somberg J Am J Ther; 2007; 14(4):321. PubMed ID: 17667203 [No Abstract] [Full Text] [Related]
17. Can the Food and Drug Administration ensure that our pharmaceuticals are safely manufactured? Hubbard WK Arch Intern Med; 2009 Oct; 169(18):1655-6. PubMed ID: 19822821 [No Abstract] [Full Text] [Related]
18. The validation life cycle. Agalloco J J Parenter Sci Technol; 1993; 47(3):142-7. PubMed ID: 8360808 [TBL] [Abstract][Full Text] [Related]
19. Drug safety: a contrarian's point of view. Cobert B Food Drug Law J; 2007; 62(3):501-12. PubMed ID: 17915392 [No Abstract] [Full Text] [Related]
20. The drug safety system conundrum. Tiedt TN Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396 [No Abstract] [Full Text] [Related] [Next] [New Search]